Wayne Foster
Insider Reports History
- Location
- Boston, MA
- Signature
- /s/ Andrea Corcoran, as Attorney-in-Fact for Wayne Foster
- All insider transactions
- Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date
Holdings reported by Wayne Foster:
| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Atea Pharmaceuticals, Inc. | EVP, Chief Accounting Officer | Common Stock | 79,329 | $336,354 | $4.24 | 31 Jan 2026 | Direct |
| Atea Pharmaceuticals, Inc. | EVP, Chief Accounting Officer | Restricted Stock Units | 0 | $26,891 | $3.36 | 31 Jan 2026 | Direct |
| Atea Pharmaceuticals, Inc. | EVP, Chief Accounting Officer | Stock Option (Right to Buy) | 108,000 | 31 Jan 2026 | Direct |
Insider Reports Filed by Wayne Foster
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | 31 Jan 2026 | 5 | -$51,440 | 4 | EVP, Chief Accounting Officer | 03 Feb 2026, 19:42 |
| AVIR | Atea Pharmaceuticals, Inc. | 31 Jan 2025 | 6 | -$36,910 | 4 | EVP, Chief Accounting Officer | 04 Feb 2025, 18:00 |
| AVIR | Atea Pharmaceuticals, Inc. | 31 Jan 2024 | 4 | -$47,904 | 4 | EVP, Chief Accounting Officer | 02 Feb 2024, 21:26 |
| AVIR | Atea Pharmaceuticals, Inc. | 31 Jan 2023 | 2 | $0 | 4 | EVP, Chief Accounting Officer | 02 Feb 2023, 17:38 |
| AVIR | Atea Pharmaceuticals, Inc. | 31 Jan 2022 | 1 | $0 | 4 | EVP, Chief Accounting Officer | 02 Feb 2022, 16:15 |